Tianjin, China – October 02, 2026 -- Tianjin University's "Shengong-Shengao" system has become China's first approved brain-computer interface (BCI) medical device for diagnosing cognitive impairment, cutting diagnosis time for conditions like hydrocephalus from days to just 30 minutes. The milestone marks a commercial breakthrough as TJU, China's first modern university, marks its 131st anniversary on October 2, 2026.

Hong Kong – – October 02, 2026 -- Ascletis Pharma Inc. (HKEX: 1672) presented preclinical data showing its ASC36_35FDC injectable combination drove a 24.8% body-weight reduction in a diet-induced obesity rat model on Day 14, outperforming two competitor co-formulations tested under identical dosing conditions.

The data were unveiled in a short oral discussion at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting, held September 28–October 2, 2026, in Milan, Italy.

Suzhou – October 02, 2026 -- Novartis has agreed to pay Abogen Biosciences an upfront fee of USD 575 million to secure worldwide rights to ABO2203, an mRNA-encoded CD19xCD3 T-cell engager for autoimmune diseases, with total deal value reaching up to approximately USD 7.2 billion if all milestones and options are exercised.

Beijing – October 02, 2026 -- iQIYI's AIGC film series "The Ferry Man" has generated cumulative revenue-sharing earnings exceeding RMB 8 million (US$1.2 million) as of September 23, validating artificial intelligence as a financially viable film production model. The milestone arrives as the third installment, "The Ferry Man: The Dream of the Princess", debuts October 1 on iQIYI and iQIYI International.

Milan – October 02, 2026 -- Hansoh Pharma's dual-biased GLP-1/GIP receptor agonist Olatorepatide (HS-20094) achieved a mean weight loss of 19.3% at Week 48 in the 15 mg dose group of a Phase III Chinese trial, with no plateau observed in the weight-loss curve.

Pune, India – October 01, 2026 -- The global elastomers market is projected to grow from $104.73 billion in 2025 to $149.19 billion by 2034, a compound annual growth rate of 4.01% through the forecast period, according to Maximize Market Research.

Singapore – September 30, 2026 -- Emerald Clinical Trials has appointed Michael Stibilj as Chief Executive Officer, effective October 1, 2026, tasking the 30-year CRO veteran with leading the next phase of growth for a platform that now spans more than 1,000 professionals across 40-plus countries and 70-plus locations.

Pune, India – – September 30, 2026 -- The global battery electrolyte market is projected to grow from $12.22 billion in 2025 to $50.98 billion by 2034, expanding at a compound annual growth rate of 17.2%, according to a new analysis by Maximize Market Research.

Shenzhen, China – September 30, 2026 -- MemoMind, the AI hardware brand incubated by projector maker XGIMI, has rolled out a software update for its MemoMind One smart glasses that expands live two-way translation to 53 languages and opens the second phase of developer access.

Vancouver – – September 30, 2026 -- Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) has extended its shareholder proxy voting deadline to September 30, 2026 at 4:00 p.m. Pacific time, after approving a further revision to a special resolution governing amendments to the Company's corporate Articles ahead of its annual general and special meeting scheduled for October 2, 2026.